Mao‐xu Ge

Statistics

Publications

Citations

404

H-Index

Active since

2015

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

National Health and Family Planning Commission

Qilu Hospital of Shandong University

Shandong University

University of Electronic Science and Technology of China

Mao‐xu Ge is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in liver disease, hepatic fibrosis, and hepatology.

ORCID

Publications per year

2015–2023

Publications

The anti‐hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes‐associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy

Mao‐xu Ge, Hong Liu, Yixuan Zhang et al. · British Journal of Pharmacology · 2017 · 65 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Costunolide represses hepatic fibrosis through WW domain‐containing protein 2‐mediated Notch3 degradation

Mao‐xu Ge, Hong‐tao Liu, Na Zhang et al. · British Journal of Pharmacology · 2019 · 64 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct–Ligated Mouse

Shi‐Ying Cai, Mao‐xu Ge, Albert Mennone et al. · Cellular and Molecular Gastroenterology and Hepatology · 2019 · 50 citations · Full text

Medicine, Immunology, Pathology +17

Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation

Zhen-Ning Lu, Weixiao Niu, Na Zhang et al. · Acta Pharmacologica Sinica · 2021 · 39 citations · Full text

Medicine, Cell Biology, Pharmacology +16

A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters

Mao‐xu Ge, Weixiao Niu, Jinfeng Ren et al. · Acta Pharmacologica Sinica · 2018 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

1–5 of 12